THERESON S.p.A. develops medical device technologies for the treatment of diabetic foot ulcers. The company offers DIAPASON, a medical device that includes a console, which generates the electrical signals and includes patient interface, display, and commands for ease of use and self-treatment at home; and a set of emitters connected to the console that convert the electrical signals into pulsating magnetic fields for systemic treatment and treatment of the ulcer area by using therapeutic magnetic resonance technology. THERESON S.p.A. was founded in 2011 and is based in Vimercate, Italy.